| Oncogene addiction to GNAS in GNASR201 mutant tumors A More, I Ito, V Haridas, S Chowdhury, Y Gu, P Dickson, N Fowlkes, ... Oncogene 41 (35), 4159-4168, 2022 | 18 | 2022 |
| Serum tumor markers and outcomes in patients with appendiceal adenocarcinoma A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ... JAMA Network Open 7 (2), e240260-e240260, 2024 | 12 | 2024 |
| Adipocyte-Specific Ablation of PU.1 Promotes Energy Expenditure and Ameliorates Metabolic Syndrome in Aging Mice Chen KY, De Angulo A, Guo X, More A, Ochsner SA, Lopez E, Saul D, Pang W ... Frontiers in Aging 2 (2673-6217), 2022 | 7 | 2022 |
| Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma J Dansby, A More, M Zeineddine, A Yousef, A Bent, F Dayyani, R Wolff, ... The Oncologist 28 (12), e1303-e1305, 2023 | 1 | 2023 |
| Goblet cell tumors of the appendix: Clinical and molecular features. AMG Yousef, ZA Naini, MA Zeineddine, S Chowdhury, J Dansby, A More, ... Journal of Clinical Oncology 41 (4_suppl), 223-223, 2023 | | 2023 |
| Utility of tumor marker levels in predicting survival of patients with appendiceal adenocarcinoma. AMG Yousef, A More, MA Zeineddine, S Chowdhury, Y Gu, J Dansby, ... Journal of Clinical Oncology 41 (4_suppl), 221-221, 2023 | | 2023 |
| Abstract 822: Oncogene addiction to GNAS in GNASR201 mutant tumors A More, V Haridas, I Ito, S Chowdhury, Y Gu, NW Fowlkes, JP Shen AACR 82 (12_Supplement), 822, 2022 | | 2022 |